Eli Lilly busca aprovação do FDA para Zepbound no tratamento de apneia do sono

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Eli Lilly busca aprovação do FDA para Zepbound no tratamento de apneia do sono

/jornal/2024/06/eli-lilly-busca-aprovacao-do-fda-para-zepbound-no-tratamento-de-apneia-do-sono/

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lilly Drn Charts.

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lilly Drn Charts.

News

More News Articles

Decentral Life (PK)

Good Vibrations Shoes (PK)

Virexit Technologies (PK)

Code Green Apparel (PK)

Bioelectronics (PK)

Moon Equity (PK)

Rennova Health (CE)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions